Suppr超能文献

经全身照射或全淋巴照射预处理的小鼠同种异体骨髓嵌合体中的移植物抗宿主反应及移植物抗白血病效应

Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.

作者信息

Salam A, Waer M

机构信息

Laboratory for Experimental Transplantation, University of Leuven, Belgium.

出版信息

Transplantation. 1996 Mar 15;61(5):826-30. doi: 10.1097/00007890-199603150-00025.

Abstract

To investigate whether graft-versus-host reactivity (GVHR) and the graft-versus-leukemia (GVL) effect can be differentiated, C3H-->AKR mixed bone marrow (BM) chimeras were prepared using two different conditioning regimens. Total body irradiation (TBI) chimeras were induced by infusing 5 x 1O(6) T cell depleted syngeneic AKR BM cells together with 15 x 1O(6) non T cell depleted allogeneic C3H BM cells 1 day after a single fraction of 10.5 Gy TBI. Total lymphoid irradiation (TLI) chimeras were prepared by injecting only 15 x 10(6) non T cell depleted C3H BM cells after 10 daily fractions of 2 Gy TLI Both groups of chimeras were healthy, without clinical or histological signs of graft-versus-host disease (GVHD). In both groups, clonal deletion of antihost-reactive donor type T lymphocytes was found. Whereas TBI chimeras did resist rejection by host type splenocytes injected 2 months after transplantation, TLI chimeras did not. As the latter phenomenon is believed to reflect remaining GVHR, TLI chimeras did have a lower remaining GVHD capacity than TBI chimeras. Nevertheless, TLI chimeras survived significantly longer after host type leukemia challenge (injection of 6 x 10(6) AKR lymphoma cells). The better survival of the TLI chimeras was not due to the radiation regimen, because TLI or TBI conditioned syngeneic AKR-->AKR BM recipients did succumb equally rapidly after AKR lymphoma injection. Donor type (CM) lymphokine-activated killer cell activity, however, was higher in TLI chimeras and may explain the better GVL activity in TLI mice. This model thus illustrates that GVHD and GVL effects can be dissociated and are differentially influenced by the conditioning regimen used for BM transplantation.

摘要

为了研究移植物抗宿主反应性(GVHR)和移植物抗白血病(GVL)效应是否可以区分,使用两种不同的预处理方案制备了C3H→AKR混合骨髓(BM)嵌合体。全身照射(TBI)嵌合体是通过在单次10.5 Gy TBI照射1天后,输注5×10⁶个去除T细胞的同基因AKR BM细胞和15×10⁶个未去除T细胞的异基因C3H BM细胞诱导产生的。全淋巴照射(TLI)嵌合体是通过在每日2 Gy的TLI照射10次后,仅注射15×10⁶个未去除T细胞的C3H BM细胞制备的。两组嵌合体均健康,无移植物抗宿主病(GVHD)的临床或组织学迹象。在两组中,均发现了抗宿主反应性供体型T淋巴细胞的克隆缺失。虽然TBI嵌合体确实抵抗了移植后2个月注射的宿主型脾细胞的排斥,但TLI嵌合体没有。由于后一种现象被认为反映了残留的GVHR,TLI嵌合体的残留GVHD能力低于TBI嵌合体。然而,在宿主型白血病攻击(注射6×10⁶个AKR淋巴瘤细胞)后,TLI嵌合体存活的时间明显更长。TLI嵌合体更好的存活不是由于照射方案,因为TLI或TBI预处理的同基因AKR→AKR BM受体在注射AKR淋巴瘤后同样迅速死亡。然而,TLI嵌合体中供体型(CM)淋巴因子激活的杀伤细胞活性更高,这可能解释了TLI小鼠中更好的GVL活性。因此,该模型表明GVHD和GVL效应可以分离,并且受到用于BM移植的预处理方案的不同影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验